Abstract
The GWAS data for the ARIC study is available in dbGAP. 142
Genetic Analyses: All analyses were performed using the R statistical software environment (R 143 Development Core Team 2012) with the addition of the Survival package (Therneau 2012) . In 144 addition, for the GWAS data, we used the Rserve (Urbanek 2012) package in R to link with the 145 8 PLINK software package (Purcell et al. 2007; Purcell 2012 ). After excluding those on primary 146 cholesterol medications, we fit the following linear model separately in both populations: 147
where APOE is a variable with 6 levels (one for each genotype). The significance of the 149 interaction term was assessed using full versus reduced models. Significance of this test rejects 150 the null hypothesis that the correlation between the two traits is equal across genotype classes 151 and that the beta coefficients from each bivariate regression within genotypes do not differ. 152
Because there are three alleles (e2, e3, e4), APOE isoform data is often collapsed to two alleles 153 (e4, non-e4) to make it easier to paramaterize (i.e. additive, dominance). We did not do this 154 because there was no linear additive relationship among the genotypes in Boerwinkle et al. 155 (1987) . As a result, we used all five degrees of freedom available from the six possible 156 genotypes. The ARIC study is large enough (see Tables 1 & 2) to have many individuals for  157 even the rarest genotypic classes (i.e. e2e2 & e4e4). 158
Because both TC and TG are positively correlated with CHD in the general population, we 159 hypothesized that the APOE genotypes change the relationship of one or both of these lipids with 160 CHD. A Cox Proportional Hazards model was used to test whether TC and/or lnTG interacts 161
with APOE with respect to CHD separately in each population. A full versus reduced model 162 likelihood ratio test was used to test for significance of the APOE*TC and APOE*lnTG terms in 163 each model. The Cox Proportional Hazards model is a semiparametric survival method that uses 164 a partial log-likelihood to estimate the effect of independent variables on the hazard function in 165 relation to time to event data. It assumes a parametric form for the effect of the predictors on the 166 hazard function; but unlike parametric models, it does not make any assumptions about the shape 167 of the baseline hazard function (Agresti 2002) . Below is the model including lnTG, the other 168 model replaces lnTG with TC. 169 In a posthoc analysis with the components of TC, we found that LDL also has a strong 223 relationship (p = 9.6 x 10 -6 EA; p = 1.4 x 10 -5 AA) with lnTG as observed before but the 224 relationship of lnTG with HDL was weak or negligible (p = 0.013 EA; p = 0.264 AA). In 225 African-Americans LDL had a stronger interaction (yet similar pattern) with APOE genotype to 226 affect CHD than APOE*TC (p=0.0066 for APOE*LDL vs p=0.016 for APOE*TC) while there 227 was no evidence for an APOE*HDL interaction. There was no evidence for an APOE*LDL or 228 APOE*HDL interaction in the European-American population.
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The covariate adjusted correlation between TC and lnTG in the general population (0.24 230 for AA and 0.33 EA) is reflective of the e3e3 genotype, which is by far the most common 231 genotype. This is also true for hazard ratios for CHD/TC (in AA) and CHD/lnTG (in EA). The 232 risk relationship seen in the general population is a weighted average with e3e3 providing the 233 largest influence while other the other less common genotypes pull in opposite directions 234 (Figure 1) . TC in AA and lnTG in AA have much a stronger positive CHD risk for individuals 235 with the e2e2 & e2e3 genotypes while there is no risk (or negative) for those with e2e3 or e4e4. 236
Initially, ten loci were found that significantly interact with APOE in African Americans, 237 one for incident CHD, six for TC, one for LDL, and two for HDL. Six loci were found for 238
European Americans and they were all for TC. However, from QQ plots we found the scans for 239 TC and LDL showed p-value inflation while CHD and HDL did not (see Supplemental Figure  240 To obtain an empirical estimate of the p-values for the TC (6 EA, 6 AA) and LDL (1 AA) 248 loci, for each locus we simulated 100 million parametric bootstraps to compare with the original 249 statistic. Only one TC locus remained significant leaving four significant loci that interact with 250 APOE in African Americans (see Figure 2 and Table 3 ). Plots and descriptions of the other loci 251 just under significance can be seen in Supplemental Table S1 and Figures S1 and S2 . 252
Stratification could be a source of confounding for analyses in the African-American 253 population. Principal components were available for a subset of the individuals with APOE and 254 13 GWAS data (1986 AA). Because of the loss of individuals (368), we decided to do the 255 analyses with all of the available data (without the principal components) and for each genome-256 wide significant locus we used the smaller dataset and the first two principal components as 257 covariates to test for consistency. Using the smaller dataset and including the principal 258 components, each of the loci found in African-Americans showed the same effects and remained 259 highly significant. The original rQTL models with APOE in African-Americans were also tested 260 using the smaller dataset and each retained significance. 261
There is no obvious functional information about the region around rs16828155 that 262 connect is to CHD risk but a study (Lunetta et al. 2007 ) using the Framingham Heart Study 263 found a GWAS hit (rs1412337) 166 KB upstream for morbidity-free survival at age 65. 264 rs16828155 has a strong additive relationship with CHD risk among African-American 265 individuals that carry at least one APOE e2 allele and none for those without an e2 allele (see 266 Using an analogous Cox Proportional Hazards model with incident CHD, the APOE*rs912618 275 interaction term was not significant (p=0.11); however, the direction of effects was as expected. for those loci with sufficient counts for e2e4, we found opposing effects for CHD and lnTG in 307 EA (5 of 6) and CHD and TC in AA (4 of 7). All but one (12 of 13) found opposing direction of 308 effects for TC and lnTG in e4e4 while most showed opposing direction of effects for TC and 309 CHD in EA (5 of 6) and lnTG and CHD in AA (5 of 7). It is not expected that all loci that 310 interact with APOE will contribute to this specific rQTL, but these loci appear to contribute to 311 the bivariate relationship differences among APOE genotypes (see Figure 1) . 312
Besides APOE itself, none of the other interacting loci have even a nominal association 313 directly with the trait itself such that none of these loci would be found by a standard single locus 314 GWAS. This is consistent with other rQTL studies (Pavlicev et al. 2011) . The rQTL approach, as demonstrated here, is a powerful way to identify loci that effect 328 relationships between important biological risk factors and the relationship between these factors 329 and disease. In our case, the rQTL (APOE) was already known; however, the same model used 330 to validate APOE as an rQTL can be used in a genome-wide scan to identify other previously 331 unknown rQTL for a given pair of traits. These loci would typically be undetected in a normal 332 GWAS analysis and even if "seen", their role in pleiotropic variation and gene-by-gene 333 interactions would not be evident. It is also a unique, efficient, and powerful approach to 334 identifying gene-by-gene interactions. It enhances statistical power by defining a priori loci 335 (rQTL) that are likely to be involved in an interaction and reducing the number of tests to the 336 order of a GWAS instead of all pairwise tests. 337
Biologically, it provides a framework to link multiple traits together and with the rQTL 338 and other interacting loci. In the context of human medicine, these loci can lead to further 339 insights about conditions where the magnitude of risk for a known risk factor changes. In the 340 case of triglycerides in European-Americans and total cholesterol (and LDL) in African-341 Various studies have shown that APOE alleles respond differently to different types of 358 LDL-lowering treatments. Response (reduction in LDL) to exercise is greater for those with the 359 e3 allele than the e4 allele. Statins produce a similar pattern while Probucol, which has a 360 different target and mechanism for lowering LDL than statins, has the opposite effect with a 361 greater response for those carrying the e4 allele (Hagberg et al. 2000) . Gustavsson et al. (2012) 362 found that APOE genotypes interact with both smoking and physical inactivity with respect to 363 CHD. They determined that these interactions were independent of LDL levels and concluded 364 that something other than a direct effect on lipid levels is responsible for this relationship with 365
CHD. 366
While APOE has a similar effect on the correlation between TC and lnTG in both 367 populations, it is surprising to see that APOE only affects the relationship between TC and CHD 368 
